BioCentury
ARTICLE | Clinical News

RG7159: Completed Phase I/II enrollment

August 3, 2009 7:00 AM UTC

Roche disclosed that last quarter it completed enrollment of 80 patients with indolent and aggressive non-Hodgkin's lymphoma (NHL) in the first arm of the Phase II portion of the open-label, dose-esca...